BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37498160)

  • 1. Dynamics simulation and in vitro studies of betulinic acid derivative with liver X receptor.
    Yu P; Cao W; Wang Y
    J Biomol Struct Dyn; 2023 Jul; ():1-10. PubMed ID: 37498160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer.
    Suri C; Naik PK
    SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
    Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
    J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
    Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
    J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput molecular dynamics screening (HTMDS) approach to the design of novel cyclopeptide inhibitors of ATAD2B based on the non-canonical combinatorial library.
    Chen Z; Li Y; Wang X; Qiu X; Wang C; Wang Z; Chen X; Wang J
    J Biomol Struct Dyn; 2024 Apr; 42(6):2809-2824. PubMed ID: 37194299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation and free energy calculation studies of Coagulin L as dipeptidyl peptidase-4 inhibitor.
    Singh A; Mishra A
    J Biomol Struct Dyn; 2022 Feb; 40(3):1128-1138. PubMed ID: 33078683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and molecular dynamics simulations of a mutant
    Anuar NFSK; Wahab RA; Huyop F; Amran SI; Hamid AAA; Halim KBA; Hood MHM
    J Biomol Struct Dyn; 2021 Apr; 39(6):2079-2091. PubMed ID: 32174260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate.
    Ahmad S; Almanaa TN; Khan S; Aljahdali SM; Waheed Y; Aljasir MA; Al-Megrin WAI; Aziz A; Ateeq M; Amin F; Khattak SU; Sanami S
    J Biomol Struct Dyn; 2023 Dec; ():1-9. PubMed ID: 38064307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking and molecular dynamics simulation of
    Oyewusi HA; Huyop F; Wahab RA
    J Biomol Struct Dyn; 2022 Mar; 40(5):1979-1994. PubMed ID: 33094694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
    Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
    Taidi L; Maurady A; Britel MR
    J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Oyewusi HA; Huyop F; Wahab RA; Hamid AAA
    J Biomol Struct Dyn; 2022; 40(19):9332-9346. PubMed ID: 34014147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Elkaeed EB; Yousef RG; Elkady H; Mehany ABM; Alsfouk BA; Husein DZ; Ibrahim IM; Metwaly AM; Eissa IH
    J Biomol Struct Dyn; 2023; 41(16):7986-8001. PubMed ID: 36184591
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
    Purohit P; Dash JJ; Muya JT; Meher BR
    J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding Interaction of Betulinic Acid to α-Glucosidase and Its Alleviation on Postprandial Hyperglycemia.
    Chen S; Lin B; Gu J; Yong T; Gao X; Xie Y; Xiao C; Zhan JY; Wu Q
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity.
    Hammoud MM; Khattab M; Abdel-Motaal M; Van der Eycken J; Alnajjar R; Abulkhair HS; Al-Karmalawy AA
    J Biomol Struct Dyn; 2023 Jul; 41(11):5199-5216. PubMed ID: 35674744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of binding mechanism of triclosan towards cancer markers using molecular docking and molecular dynamics.
    Bhardwaj P; Biswas GP; Mahata N; Ghanta S; Bhunia B
    Chemosphere; 2022 Apr; 293():133550. PubMed ID: 34999105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.